Pfizer Inc. PFE
NYSE
Recommendation
Dividend Power Score
Day's Range
$29.42$29.74
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/28/2026 | 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | |
|---|---|---|---|---|---|
| Revenue | 63.70B | -- | -- | -- | 63.83B |
| Total Other Revenue | 1.00M | -- | -- | -- | 0.00 |
| Total Revenue | 63.70B | -- | -- | -- | 63.83B |
| Cost of Revenue | 16.11B | -- | -- | -- | 17.48B |
| Gross Profit | 47.59B | -- | -- | -- | 46.35B |
| SG&A Expenses | 12.92B | -- | -- | -- | 14.06B |
| Depreciation & Amortization | 4.82B | -- | -- | -- | 5.09B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.86B | -- | -- | -- | 46.92B |
| Operating Income | 18.84B | -- | -- | -- | 16.91B |
| Income Before Tax | 4.21B | -- | -- | -- | 10.53B |
| Income Tax Expenses | -164.00M | -- | -- | -- | -235.00M |
| Earnings from Continuing Operations | 4.37K | -- | -- | -- | 10.77K |
| Earnings from Discontinued Operations | -5.00M | -- | -- | -- | 24.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -35.00M | -- | -- | -- | -40.00M |
| Net Income | 4.33B | -- | -- | -- | 10.75B |
| EBIT | 18.84B | -- | -- | -- | 16.91B |
| EBITDA | 25.38B | -- | -- | -- | 23.68B |
| EPS Basic | 0.76 | -- | -- | -- | 1.89 |
| Normalized Basic EPS | 2.08 | -- | -- | -- | 1.65 |
| EPS Diluted | 0.75 | -- | -- | -- | 1.89 |
| Normalized Diluted EPS | 2.08 | -- | -- | -- | 1.64 |
| Average Basic Shares Outstanding | 22.76B | -- | -- | -- | 22.69B |
| Average Diluted Shares Outstanding | 22.83B | -- | -- | -- | 22.82B |
| Dividend Per Share | 2.15 | -- | -- | -- | 2.12 |
| Payout Ratio | 225.88% | -- | -- | -- | 66.94% |